4,4-dicarboxy-5-pyridoxylproline has been researched along with aripiprazole in 1 studies
| Studies (4,4-dicarboxy-5-pyridoxylproline) | Trials (4,4-dicarboxy-5-pyridoxylproline) | Recent Studies (post-2010) (4,4-dicarboxy-5-pyridoxylproline) | Studies (aripiprazole) | Trials (aripiprazole) | Recent Studies (post-2010) (aripiprazole) |
|---|---|---|---|---|---|
| 9 | 0 | 4 | 2,989 | 509 | 1,788 |
| Protein | Taxonomy | 4,4-dicarboxy-5-pyridoxylproline (IC50) | aripiprazole (IC50) |
|---|---|---|---|
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 0.78 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.0158 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 1.945 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 1.38 | |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.17 | |
| Histamine H1 receptor | Homo sapiens (human) | 0.42 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 1.8572 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capuano, B; Christopoulos, A; Klein Herenbrink, C; Lane, JR; Szabo, M | 1 |
1 other study(ies) available for 4,4-dicarboxy-5-pyridoxylproline and aripiprazole
| Article | Year |
|---|---|
Structure-activity relationships of privileged structures lead to the discovery of novel biased ligands at the dopamine Dâ‚‚ receptor.
Topics: Animals; CHO Cells; Cricetulus; Cyclic AMP; Dopamine D2 Receptor Antagonists; Drug Partial Agonism; Ligands; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Piperazines; Piperidines; Radioligand Assay; Receptors, Dopamine D2; Structure-Activity Relationship; Thienopyridines | 2014 |